Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GSK-LSD1
Cat. No.:
OB0425LY-003
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
GSK-LSD1 is a selective inhibitor that targets LSD1 (lysine-specific demethylase 1) and plays an important role in epigenetic studies.
Synonyms:
GSK-LSD1; N-[(1R,2S)-2-Phenylcyclopropyl]piperidin-4-amine; GSK LSD1 Dihydrochloride; 1431368-48-7; N-((1R,2S)-2-Phenylcyclopropyl)piperidin-4-amine
CAS No.:
1431368-48-7
Compound CID:
71522234
Formula:
C14H20N2
Formula Weight:
216.32
Specification
Target:
Histone demethylase
Pathway:
Epigenetics
Storage:
Storage at -20°C.
Applications:
GSK-LSD1 can be used to improve insulin sensitivity and glycemic control in an obese mouse model.
